Workflow
Analyst Ratings
icon
Search documents
Top Wall Street Forecasters Revamp Cintas Expectations Ahead Of Q1 Earnings - Cintas (NASDAQ:CTAS)
Benzinga· 2025-09-19 14:39
Group 1 - Cintas Corporation is set to release its first-quarter earnings on September 24, with analysts expecting earnings of $1.2 per share, an increase from $1.1 per share in the same period last year [1] - The company's quarterly revenue is projected to be $2.7 billion, up from $2.5 billion a year earlier [1] - Cintas has increased its quarterly cash dividend from 39 cents to 45 cents as of July 29 [1] Group 2 - Cintas shares experienced a slight decline of 0.2%, closing at $199.51 [2] - Analysts have provided various ratings and price targets for Cintas, with RBC Capital setting a target of $240, Baird at $230, Morgan Stanley at $220, JP Morgan at $239, and Wells Fargo at $221 [7]
Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday - Aon (NYSE:AON), AvalonBay Communities (NYSE:AVB)
Benzinga· 2025-09-11 12:08
Group 1 - Top Wall Street analysts have revised their outlook on several prominent companies, indicating potential shifts in investment strategies [1] - Analysts are particularly focused on AON stock, suggesting it may be a viable investment option based on recent evaluations [1]
RH Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - RH (NYSE:RH)
Benzinga· 2025-09-11 07:03
Core Insights - RH is set to release its second-quarter earnings results on September 11, with analysts expecting earnings of $3.22 per share, a significant increase from $1.69 per share in the same quarter last year [1] - Projected quarterly revenue for RH is $905.36 million, up from $829.65 million a year earlier [1] Earnings Performance - In the first quarter, RH reported better-than-expected adjusted EPS results and maintained its FY25 guidance despite uncertainties related to tariffs and macroeconomic events [2] - Following the first-quarter report, RH shares fell by 1.7%, closing at $228.93 [2] Analyst Ratings and Price Targets - Wells Fargo analyst Zachary Fadem maintained an Overweight rating and raised the price target from $275 to $295 [5] - Telsey Advisory Group analyst Cristina Fernandez maintained an Outperform rating with a price target of $255 [5] - Citigroup analyst Steven Zaccone maintained a Neutral rating and increased the price target from $200 to $233 [5] - Guggenheim analyst Steven Forbes reiterated a Buy rating with a price target of $300 [5] - Goldman Sachs analyst Kate McShane downgraded the stock from Neutral to Sell, reducing the price target from $199 to $179 [5]
Top Wall Street Forecasters Revamp Tapestry Expectations Ahead Of Q4 Earnings
Benzinga· 2025-08-14 08:11
Group 1 - Tapestry, Inc. is set to release its fourth-quarter earnings results on August 14, with analysts expecting earnings of $1.02 per share, an increase from $0.92 per share in the same period last year [1] - The projected quarterly revenue for Tapestry is $1.68 billion, compared to $1.59 billion a year earlier [1] - Tapestry's shares rose by 2.4% to close at $113.53 following a renewed multi-year collaboration with Gen Phoenix, a leader in eco-friendly recycled leather fibers [2] Group 2 - Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating and raised the price target from $92 to $125 [8] - UBS analyst Jay Sole maintained a Neutral rating and increased the price target from $73 to $112 [8] - B of A Securities analyst Lorraine Hutchinson downgraded the stock from Buy to Hold while raising the price target from $95 to $115 [8] - JP Morgan analyst Matthew Boss maintained an Overweight rating and raised the price target from $104 to $145 [8] - Raymond James analyst Rick Patel reiterated an Outperform rating and boosted the price target from $85 to $115 [8]
Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Benzinga· 2025-07-16 15:43
Core Insights - Abbott Laboratories is set to release its second-quarter earnings results on July 17, with expected earnings of $1.25 per share, an increase from $1.14 per share in the same period last year [1] - The company anticipates quarterly revenue of $11.02 billion, up from $10.38 billion a year earlier [1] - Abbott received FDA approval for its Tendyne™ transcatheter mitral valve replacement system, which positively impacted its stock price [2] Analyst Ratings - Morgan Stanley analyst David Lewis maintained an Equal-Weight rating and raised the price target from $127 to $137 [5] - Raymond James analyst Jayson Bedford maintained an Outperform rating and increased the price target from $132 to $142 [5] - Barclays analyst Matt Miksic maintained an Overweight rating and slightly raised the price target from $158 to $159 [5] - Stifel analyst Rick Wise maintained a Buy rating and increased the price target from $135 to $145 [5] - Jefferies analyst Matthew Taylor maintained a Hold rating and raised the price target from $135 to $137 [5]
J.B. Hunt Transport Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Benzinga· 2025-07-08 14:17
Core Viewpoint - J.B. Hunt Transport Services, Inc. is expected to report stable earnings and revenue for the second quarter, maintaining figures from the previous year [1] Financial Performance - For the second quarter, analysts anticipate earnings of $1.32 per share, unchanged from the same period last year [1] - Projected quarterly revenue is $2.93 billion, consistent with the previous year's revenue [1] - In the first quarter, J.B. Hunt reported a 7.6% decline in profit [2] Stock Performance - Following the first quarter results, J.B. Hunt Transport shares fell by 2.2%, closing at $149.56 [2] Analyst Ratings - Truist Securities maintained a Hold rating and raised the price target from $130 to $140 [4] - Susquehanna maintained a Neutral rating and increased the price target from $140 to $155 [4] - Goldman Sachs downgraded the stock from Buy to Neutral with a price target of $164 [4] - JP Morgan maintained an Overweight rating but cut the price target from $167 to $150 [4] - UBS maintained a Buy rating and reduced the price target from $196 to $155 [4]
Top Wall Street Forecasters Revamp CarMax Expectations Ahead Of Q1 Earnings
Benzinga· 2025-06-18 15:53
Financial Performance - CarMax is set to release its first-quarter financial results on June 20, with analysts expecting earnings of $1.17 per share, an increase from $0.97 per share in the same period last year [1] - The company projects quarterly revenue of $7.53 billion, compared to $7.11 billion a year earlier [1] - CarMax reported weaker-than-expected earnings for the fourth quarter on April 10 [1] Stock Performance - CarMax shares fell by 2.2%, closing at $64.43 on Tuesday [2] Analyst Ratings - Wedbush analyst Scott Devitt reiterated an Outperform rating with a price target of $90 [4] - RBC Capital analyst Steven Shemesh maintained an Outperform rating but reduced the price target from $103 to $80 [4] - JP Morgan analyst Rajat Gupta maintained an Underweight rating and lowered the price target from $72 to $65 [4] - Truist Securities analyst Scot Ciccarelli maintained a Hold rating and increased the price target from $72 to $88 [4] - Oppenheimer analyst Brian Nagel maintained an Outperform rating with a price target of $105 [4]
Darden Restaurants Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Benzinga· 2025-06-18 07:06
Group 1 - Darden Restaurants, Inc. is set to release its fourth-quarter financial results on June 20, with expected earnings of $2.96 per share, an increase from $2.65 per share in the same quarter last year [1] - The company projects quarterly revenue of $3.26 billion, up from $2.96 billion a year earlier [1] - In the third quarter, Darden reported revenue growth of 6.2% year-on-year to $3.158 billion, which was below the analyst consensus estimate of $3.215 billion [2] Group 2 - Analyst ratings for Darden Restaurants show varied opinions, with Wells Fargo maintaining an Equal-Weight rating and increasing the price target from $200 to $225 [5] - Evercore ISI Group maintained an Outperform rating and raised the price target from $230 to $250 [5] - UBS maintained a Buy rating and boosted the price target from $225 to $245, while Jefferies upgraded the stock from Underperform to Hold and raised the price target from $165 to $210 [5]
Kirkland's Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Benzinga· 2025-06-16 11:11
Core Insights - Kirkland's, Inc. is set to release its first-quarter financial results on June 17, with analysts expecting a loss of 47 cents per share, an improvement from a loss of 65 cents per share a year ago [1] - The company projects quarterly revenue of $85.56 million, down from $91.75 million in the same quarter last year [1][2] Financial Performance - Kirkland's reported disappointing fourth-quarter 2024 results, raising concerns about its ability to continue as a going concern [2] - Following the announcement, Kirkland's shares fell by 4.8%, closing at $1.19 [2] Analyst Ratings - Benchmark analyst John Lawrence has reiterated a Buy rating with a price target of $7 as of October 23, 2024, with an accuracy rate of 62% [4] - Craig-Hallum analyst Jeremy Hamblin maintained a Hold rating and reduced the price target from $2.5 to $2 on September 6, 2024, with an accuracy rate of 68% [4]
5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Week
Benzinga· 2025-06-09 13:34
Market Overview - U.S. stocks closed higher on Friday, with the Dow Jones index gaining over 400 points following the release of jobs data [1] Analyst Ratings and Insights - Benzinga's Analyst Ratings API provides high-quality stock ratings through partnerships with major sell-side banks, displaying overnight rating changes daily [2] - Analyst insights from Benzinga Pro subscribers have been shown to outperform the stock market as trading indicators [2] Top Analyst Picks - Benzinga offers access to the latest analyst ratings, allowing traders to sort by analyst accuracy [3] - The most accurate Wall Street analysts include Trevor Walsh and Alexander Paris [3] Recent Analyst Ratings - **CrowdStrike Holdings, Inc. (CRWD)**: JMP Securities maintained an Outperform rating with a price target of $500, indicating a 6% upside [5] - **HealthEquity, Inc. (HQY)**: Barrington Research maintained an Outperform rating and raised the price target from $112 to $125, indicating a 12% surge potential [5] - **Amazon.com, Inc. (AMZN)**: JP Morgan maintained an Overweight rating and increased the price target from $225 to $240, indicating a 12% upside [5] - **LGI Homes, Inc. (LGIH)**: Wedbush maintained a Neutral rating and cut the price target from $100 to $93, indicating a 90% upside [5] - **Broadcom Inc. (AVGO)**: An analyst reiterated a Buy rating and boosted the price target from $267 to $295, indicating a 20% upside [6] Company News - CrowdStrike's CEO expressed confidence in the company's financial practices amid a Department of Justice inquiry [5] - HealthEquity reported better-than-expected first-quarter adjusted EPS results and raised its FY26 guidance [5] - Amazon cut jobs in its books division, including roles at Goodreads and Kindle [5] - LGI Homes reported 416 home closings in May [5] - Broadcom reported second-quarter revenue of $15 billion, exceeding analyst estimates of $14.99 billion [6]